What is GlaxoSmithKline Consumer Nigeria Price-to-Operating-Cash-Flow?
As of today (2024-05-26), GlaxoSmithKline Consumer Nigeria's share price is ₦17.00.
GlaxoSmithKline Consumer Nigeria's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₦5.86. Hence, GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow Ratio for today is 2.90.
The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow or its related term are showing as below:
NSA:GLAXOSMITH'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.83 Med: 13.53 Max: 46.35
Current: 2.9
During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest Price-to-Operating-Cash-Flow Ratio was 46.35. The lowest was 0.83. And the median was 13.53.
GlaxoSmithKline Consumer Nigeria's Cash Flow from Operations per share for the
three
months ended in Jun. 2023 was ₦0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₦5.86.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 270.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 114.60% per year.
During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest 3-Year average Operating Cash Flow per Share Growth Rate was 114.60% per year. The lowest was -40.70% per year. And the median was -10.70% per year.
GlaxoSmithKline Consumer Nigeria Price-to-Operating-Cash-Flow Historical Data
The historical data trend for GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Consumer Nigeria Price-to-Operating-Cash-Flow Chart
|
GlaxoSmithKline Consumer Nigeria Annual Data
|
|
Trend |
Dec13 |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
10.15 |
0.84 |
21.64 |
1.03 |
|
GlaxoSmithKline Consumer Nigeria Quarterly Data
|
|
Mar18 |
Jun18 |
Sep18 |
Dec18 |
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Jun23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
2.97 |
3.40 |
0.86 |
1.03 |
1.32 |
Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow falls into.
GlaxoSmithKline Consumer Nigeria Price-to-Operating-Cash-Flow Calculation
GlaxoSmithKline Consumer Nigeria's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 17.00 | / | 5.862 |
| = | 2.90 |
GlaxoSmithKline Consumer Nigeria's Share Price of today is ₦17.00.
GlaxoSmithKline Consumer Nigeria's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₦5.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description
Traded in Other Exchanges
N/A
Address
No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.
GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSA:GLAXOSMITH has been successfully added to your